Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Merck
FDA Approves WINREVAIR — Merck Sharp & Dohme LLC

# FDA Approves Merck's WINREVAIR (sotatercept-csrk), Expanding Treatment Options in Pulmonary Hypertension Market Merck Sharp & Dohme LLC's FDA appro...

Idorsia
FDA Approves TRYVIO — Idorsia Pharmaceuticals Ltd

Idorsia Pharmaceuticals Ltd announced on March 19, 2024, that the FDA granted approval for TRYVIO (aprocitentan) to treat pulmonary arterial hypertens...

Madrigal
FDA Approves REZDIFFRA — Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals’ FDA approval of RESMETIROM (Resmetirom) for the treatment of non-alcoholic steatohepatitis确立了首个获批用于该适应症的口服疗法,预计将确立公司作为慢性肝病治疗...

BeOne
FDA Approves TEVIMBRA — BeOne Medicines USA, Inc.

BeOne Medicines USA, Inc. received FDA approval on March 13 for TEVIMBRA (tislelizumab), an intravenous immunotherapy, marking a significant expansion...

Advagen
FDA Approves OXCARBAZEPINE — Advagen Pharma Ltd.

Advagen Pharma Ltd. announced the March 5 FDA approval of its ANDA207717 for the oral formulation of oxycarbazepine, providing clearance to market the...

BluePoint
FDA Approves CAPECITABINE — BluePoint Laboratories

BluePoint Laboratories has received marketing authorization from the FDA for its generic version of CAPECITABINE, positioning the firm to capturemarke...

Fresenius
FDA Approves TYENNE — Fresenius Kabi USA, LLC

Fresenius Kabi USA has announced FDA approval of tocilizumab (Tyenne, BLA761275) for the treatment of moderate to severe active rheumatoid arthritis, ...

Padagis
FDA Approves LENALIDOMIDE — Padagis US LLC

Padagis US LLC announced the FDA approval of its oral lenalidomide ANDA, positioning the company to compete in the generic oncology market where an in...

Kanchan
FDA Approves OXCARBAZEPINE — Kanchan Healthcare Inc

Kanchan Healthcare Inc. has achieved FDA approval for its ANDA-217782, launching the generic version of oxcarbazepine oral tablets. The move positions...

Macleods
FDA Approves FENOFIBRIC ACID — Macleods Pharmaceuticals Limited

Macleods Pharmaceuticals Limited has received FDA Approval for its Abbreviated New Drug Application (ANDA207796) for generics of the Hypercholesteremi...

Aurobindo
FDA Approves ISOTRETINOIN — Aurobindo Pharma Limited

# FDA Approves Generic Isotretinoin ANDA from Aurobindo Pharma Aurobindo Pharma Limited received FDA approval for its generic isotretinoin oral formu...

Aurobindo
FDA Approves LACOSAMIDE — Aurobindo Pharma Limited

# FDA Approves Generic Lacosamide from Aurobindo Pharma The U.S. Food and Drug Administration has approved Aurobindo Pharma Limited's generic lacosam...

Zydus
FDA Approves GABAPENTIN — Zydus Pharmaceuticals USA Inc.

Zydus Pharmaceuticals USA Inc. received FDA approval for its generic Gabapentin offering under ANDA #203934, positioning the company to capture market...

Lifestar
FDA Approves ATROPINE SULFATE — Lifestar Pharma LLC

The FDA has granted approval to Lifestar Pharma LLC’s ANDA for Atropine Sulfate Ophthalmic Solution, a generic alternative to branded versions used fo...

AUROBINDO
FDA Approves Unknown Drug — AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD announced a new drug approval today, marking a strategic expansion of its generic portfolio as the company seeks to leverage this...

Zydus
FDA Approves METHYLENE BLUE — Zydus Lifesciences Limited

# FDA Approves Zydus Lifesciences' Intravenous Methylene Blue Formulation Zydus Lifesciences Limited has received FDA approval for its intravenous me...

Novartis
FDA Approves FABHALTA — Novartis Pharmaceuticals Corporation

The FDA has approved Novartis’ NDA218276 for FABHALTA (iptacopan hydrochloride), an oral drug ultimately aiming to disrupt the complement cascade. Thi...

Biocon
FDA Approves MYCOPHENOLIC ACID — Biocon Pharma Inc.

Biocon Pharma Inc. announced the U.S. FDA approval of its Mycophenolic Acid tablets, impacting the competitive landscape by expanding generic options ...

SpringWorks
FDA Approves OGSIVEO — SpringWorks Therapeutics, Inc.

# FDA Approves SpringWorks Therapeutics' OGSIVEO for Dercum Disease Treatment SpringWorks Therapeutics, Inc. received FDA approval for OGSIVEO (nirog...

ASTRAZENECA
FDA Approves Unknown Drug — ASTRAZENECA

AstraZeneca announced Friday the FDA granted approval for [Insert Substance Name and Description Here], marking a regulatory milestone that should bol...